Pfizer Inc (PFE)
Return on equity (ROE)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 8,014,000 | 4,260,000 | -2,599,000 | -296,000 | 2,132,000 | 10,470,000 | 21,472,000 | 29,051,000 | 31,372,000 | 29,771,000 | 29,309,000 | 24,966,000 | 21,979,000 | 19,180,000 | 13,228,000 | 11,154,000 | 9,632,000 | 8,701,000 | 14,187,000 | 15,744,000 |
| Total stockholders’ equity | US$ in thousands | 88,203,000 | 92,286,000 | 87,700,000 | 92,282,000 | 89,014,000 | 96,934,000 | 99,019,000 | 100,971,000 | 95,661,000 | 92,631,000 | 87,209,000 | 82,424,000 | 77,201,000 | 75,691,000 | 70,042,000 | 68,620,000 | 63,238,000 | 65,259,000 | 64,336,000 | 65,026,000 |
| ROE | 9.09% | 4.62% | -2.96% | -0.32% | 2.40% | 10.80% | 21.68% | 28.77% | 32.79% | 32.14% | 33.61% | 30.29% | 28.47% | 25.34% | 18.89% | 16.25% | 15.23% | 13.33% | 22.05% | 24.21% |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $8,014,000K ÷ $88,203,000K
= 9.09%
Pfizer Inc's return on equity (ROE) has shown fluctuations over the period from March 31, 2020, to December 31, 2024. The ROE started at 24.21% in March 2020, displaying a healthy level of profitability relative to shareholders' equity. Subsequently, it experienced some variations, with a peak of 33.61% in June 2022, indicating strong profitability.
However, the ROE started to decline steadily after June 2022, reaching 2.40% by December 31, 2023, and turning negative in the following periods. This negative trend was further confirmed by the ROE of -2.96% in June 2024.
Nonetheless, there was a slight recovery with an increase to 9.09% by December 31, 2024. It is crucial for Pfizer Inc to analyze the factors contributing to this downward trend in ROE and implement strategic initiatives to enhance profitability and ensure sustainable returns for its shareholders in the future.
Peer comparison
Dec 31, 2024